Karen Bergman | VP, IR & Corporate Communications |
Thomas Neff | Founder, Chairman & CEO |
Peony Yu | Chief Medical Officer |
Christine Chung | SVP, China Operations |
Elias Kouchakji | SVP Clinical Development, Drug Safety & Pharmacovigilance |
Pat Cotroneo | CFO |
Michael Yee | Jefferies |
Adam Walsh | Stifel, Nicolaus & Company |
Geoffrey Porges | SVB Leerink |
Joel Beatty | Citigroup |
Andy Hsieh | William Blair & Company |
Difei Yang | Mizuho Securities |
Welcome to the FibroGen's Fourth Quarter and Full Year 2018 Financial Results Conference Call. My name is Adrienne, and I'll be your operator for today's call. [Operator Instructions]. Please note this conference is being recorded.
For opening remarks and introduction, I'll now turn the call over to Ms.